SILEXION THERAPEUTICS CORP Basic Shares Outstanding (Weighted Average)
SILEXION THERAPEUTICS CORP (SLXN) reported Basic Shares Outstanding (Weighted Average) of 687.35 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-14
- SILEXION THERAPEUTICS CORP weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 687.35K shares, a 1086.07% increase year-over-year.
- SILEXION THERAPEUTICS CORP weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 323.04K shares, a 614.72% increase year-over-year.
- SILEXION THERAPEUTICS CORP weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was -1.64M shares.
- SILEXION THERAPEUTICS CORP weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 1.13M shares, a 2521.10% increase year-over-year.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 687.35K shares 10-Q · filed 2026-08-14 | 506.20K shares 10-Q · filed 2026-08-14 | -209.82K shares derived: average of 3 quarters · filed 2026-08-14 | 125.80K shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | 323.04K shares S-1/A · filed 2026-08-10 | 3.23M shares 10-Q · filed 2026-05-15 | -658.41K shares derived: average of 2 quarters · filed 2026-08-10 | -61.39K shares derived: average of 3 quarters · filed 2026-08-10 | -31.55K shares derived: average of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | -1.64M shares derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-10 | -253.60K shares derived: average of 2 quarters · filed 2026-08-10 | -149.75K shares derived: average of 3 quarters · filed 2026-08-14 | 132.95K shares S-1/A · filed 2026-08-10 | 1.33M shares 10-K · filed 2026-03-17 | |||
| 2025-09-30 | 1.13M shares 10-Q · filed 2025-11-12 | 595.30K shares derived: average of 2 quarters · filed 2026-08-14 | 723.89K shares 10-Q · filed 2025-11-12 | 298.51K shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | 57.95K shares 10-Q · filed 2026-08-14 | 579.52K shares 10-Q · filed 2025-08-12 | 51.61K shares 10-Q · filed 2026-08-14 | 516.11K shares 10-Q · filed 2025-08-12 | 20.46K shares derived: average of 3 quarters · filed 2026-08-14 | 26.15K shares derived: average of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | 45.20K shares S-1/A · filed 2026-08-10 | 6.78M shares 10-Q · filed 2025-05-13 | 1.71K shares derived: average of 2 quarters · filed 2026-08-10 | 15.54K shares derived: average of 3 quarters · filed 2026-08-10 | 13.52K shares derived: average of 4 quarters · filed 2026-08-10 | |||
| 2024-12-31 | -41.78K shares derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-10 | 717.00 shares derived: average of 2 quarters · filed 2026-08-10 | 2.96K shares derived: average of 3 quarters · filed 2026-08-10 | 4.16K shares S-1/A · filed 2026-08-10 | 623.85K shares 10-K · filed 2025-03-18 | |||
| 2024-09-30 | 43.21K shares 10-Q · filed 2025-11-12 | 5.83M shares 10-Q · filed 2024-11-14 | 25.33K shares derived: average of 2 quarters · filed 2025-11-12 | 19.47K shares 10-Q · filed 2025-11-12 | 2.62M shares 10-Q · filed 2024-11-14 | -706.06K shares derived: average of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | 7.44K shares 10-Q · filed 2025-08-12 | 250.85K shares 10-Q · filed 2024-08-29 | 7.47K shares 10-Q · filed 2025-08-12 | 251.66K shares 10-Q · filed 2024-08-29 | -955.82K shares derived: average of 3 quarters · filed 2025-08-20 | -465.48K shares derived: average of 4 quarters · filed 2025-08-20 | ||
| 2024-03-31 | 111.73K shares 10-Q · filed 2025-05-13 | -1.44M shares derived: average of 2 quarters · filed 2025-08-20 | -623.12K shares derived: average of 3 quarters · filed 2025-08-20 | -404.23K shares derived: average of 4 quarters · filed 2025-08-20 | ||||
| 2023-12-31 | -2.99M shares derived: 8-K 12 month − 10-Q 9 month · filed 2025-08-20 | -990.54K shares derived: average of 2 quarters · filed 2025-08-20 | -576.21K shares derived: average of 3 quarters · filed 2025-08-20 | 7.49K shares 8-K · filed 2025-08-20 | 111.73K shares 10-K · filed 2025-03-18 | |||
| 2023-09-30 | 1.01M shares 10-Q · filed 2024-11-14 | 629.00K shares derived: average of 2 quarters · filed 2024-11-14 | 1.01M shares 10-Q · filed 2024-11-14 | |||||
| 2023-06-30 | 252.46K shares 10-Q · filed 2024-08-29 | 252.46K shares 10-Q · filed 2024-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |